Altered states of consciousness through yoga, mindfulness more common than thought and mostly beneficial, study finds — though clinicians ill-equipped to help those who struggle
The first family-based genome-wide association study in Alzheimer’s disease has identified the sites of four novel genes that may significantly influence risk for the most common late-onset form of the…
Boston Mayor Thomas M. Menino and the city’s top health official, Barbara Ferrer, speaking at the Harvard School of Public Health’s (HSPH) 18th Annual Community Partnership Day, said efforts to end racial health disparities must go forward in the city even as the nation’s economy falters.
The quality of hospitals across the United States is inconsistent. To address this issue, the federal government and private organizations have begun to publicly report data, such as how well hospitals treat certain conditions. But until now, there has been no data on how patients themselves feel about the care they received. A new study by Harvard School of Public Health (HSPH) researchers analyzed the first national data on patients’ experiences in hospital settings and found that though patients are generally satisfied with their care, there is substantial room for improvement in a number of key areas, including pain management and discharge instructions.
As part of the ongoing poll series “Debating Health: Election 2008,” the Harvard Public Opinion Research Program at the Harvard School of Public Health (HSPH) and Harris Interactive conducted a new survey focused on whether voters believe the results of this presidential election will make “a great deal of difference” in the state of the nation’s health care and other key policy areas. Although much has been made of voter cynicism in recent times, a majority of registered voters believe the outcome of this election will make a great deal of difference on key issues including the war in Iraq (63 percent), the economy (52 percent), the war in Afghanistan (50 percent), and national security (50 percent). This survey was conducted Oct. 16-19 by telephone among a national cross section of 957 registered voters in the United States.
A team of researchers led by Harvard School of Dental Medicine (HSDM) Dean for Research Bjorn Olsen has discovered a mechanism for the rapid growth seen in infantile hemangioma, the most common childhood tumor.
Just getting there takes hours of hot, sweaty hiking through lowland Papua New Guinea forests: three hours from the road to the base camp, then another seven to the site. That’s when the real work begins: tagging, measuring, and identifying 250,000 trees scattered over 50 hectares.
Massachusetts General Hospital (MGH) researchers have used gene therapy to restore useful vision to mice with degeneration of the light-sensing retinal rods and cones, a common cause of human blindness. Their report, appearing in the Oct. 14 Proceedings of the National Academy of Sciences, describes the effects of broadly expressing a light-sensitive protein in other neuronal cells found throughout the retina.
Harvard biologist Edward O. Wilson said the Earth’s major biological hot spots could be conserved for roughly $50 billion— an amount he termed “chump change” in a world of trillion-dollar financial bailouts.
Scientists at Dana-Farber Cancer Institute have identified a previously undetected trigger point on a naturally occurring “death protein” that helps the body get rid of unwanted or diseased cells. They say it may be possible to exploit the newly found trigger as a target for designer drugs that would treat cancer by forcing malignant cells to commit suicide.
The world moved a step deeper into the DNA age Monday (Oct. 20) as 10 volunteers released their genetic and medical information on the Internet as part of a multiyear effort to make genetic data an everyday part of medical care.
Researchers at Dana-Farber Cancer Institute have identified a set of previously unknown mutations in a single gene in 8 percent of neuroblastomas, tumors of the nervous system that occur in young children and account for approximately 15 percent of all childhood cancer deaths.
Back in the depths of time, an event almost miraculously improbable happened, creating a long, unlikely molecule. And life arose on Earth. Or, if you prefer, back in the depths of time, in a soup of small, relatively common molecules, an unknown chemical reaction occurred, sustained itself, replicated … and life arose on Earth.
In the United States, a black man can expect to die, on average, 10 years earlier than his white counterpart. For black women, that racial gap in life expectancy is five years.
Harvard Medical School researchers at Dana-Farber Cancer Institute have identified a previously undetected trigger point on a naturally occurring “death protein” that helps the body get rid of unwanted or…
The world moved a step deeper into the DNA age yesterday as 10 volunteers released their genetic and medical information on the Internet as part of a multi-year effort to…
In a Siberian cave Patrick Wrinn found bones: bones of sheep and goats, bones of extinct bison and horses, of mammoths and wooly rhinoceroses. Wrinn, a doctoral student in archaeology at the University of Arizona and member of the Harvard Class of 1998, is trying to find out who — or what — put the bones there.
Imagine, if you can, a day within the next decade when a physician-scientist could remove a skin cell from your arm and with a few chemicals turn that fully formed adult cell into a dish of stem cells genetically matched to you.
Hospital-sponsored stop-smoking programs for inpatients that include follow-up counseling for longer than one month significantly improve patients’ ability to stay smoke-free. An analysis of clinical trials of programs offered at hospitals around the world finds that efforts featuring long-term support can increase participants’ chances of success by 65 percent.
Scientists have reached a critical milestone in the study of liver cancer that lays the groundwork for predicting the illness’s path, whether toward cure or recurrence. By analyzing the tissue in and around liver tumors, an international research team has identified a kind of genetic “fingerprint” that can help predict whether cancers will return.
Decades after predicting Latinos will become California’s majority, a leading researcher into Latino health argued Wednesday (Oct. 8) that the development might mean a healthier population.
Caffeine consumption does not appear to be associated with overall breast cancer risk, according to a report in the Oct. 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. However, there is a possibility of increased risk for women with benign breast disease or for tumors that are hormone-receptor negative or larger than 2 centimeters.
Ken Ishitani of Brigham and Women’s Hospital and Harvard Medical School, and Tokyo Women’s Medical University, Japan, and colleagues report in the Oct. 13 issue of Archives of Internal Medicine…
Imagine, if you can, a day within the next decade when a physician-scientist could remove a skin cell from your arm, and with a few chemicals turn that fully formed adult cell into a dish of stem cells genetically matched to you.
Engineer, entrepreneur, and philanthropist Hansjörg Wyss, M.B.A. ’65 has given Harvard University $125 million to create the Hansjörg Wyss Institute for Biologically Inspired Engineering.
Higher levels of testosterone are correlated with financial risk-taking behavior, according to a new study in which men’s testosterone levels were assessed before participation in an investment game. The findings help to shed light on the evolutionary function and biological origins of risk taking.
A team of Harvard Stem Cell Institute (HSCI) scientists has taken an important step toward producing induced pluripotent stem (iPS) cells that are safe to transplant into patients to treat diseases. Excitement over the ability of researchers to create this form of stem cell by inserting four genes into adult cells has thus far been tempered by the fact that the genes have been inserted using retroviruses, which have the potential to “turn on” cancer genes and trigger tumor growth.
Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors — delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading. An animal study described in the journal Molecular Therapy, the first study to test the feasibility of such an approach, found that inducing mouse brain cells to secrete human interferon-beta, a protein, suppressed and eliminated growth of human glioblastoma cells implanted nearby.
Researchers at Harvard Medical School and the University of Wisconsin, Madison, have discovered how beetles and bacteria form a symbiotic and mutualistic relationship — one that ultimately results in the…
Julio Frenk, who will become Dean of Harvard School of Public Health in January, 2009, has received a Clinton Global Citizen Award. In naming Frenk, along with four other individuals,…
Featured series 
